Management of medication overuse headache

Drug and Therapeutics Bulletin

Volumn 48, Issue 1, 2010, Pages 2-6

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; CODEINE; DIHYDROCODEINE; DOMPERIDONE; ERGOT ALKALOID; METOCLOPRAMIDE; NAPROXEN; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PREDNISOLONE; TOPIRAMATE; TRIPTAN DERIVATIVE;

ACUPUNCTURE; ANAMNESIS; BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; DEPRESSION; DRUG ACCUMULATION; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; HEADACHE; HUMAN; MASSAGE; MIGRAINE; MOOD DISORDER; PREVALENCE; PROPHYLAXIS; RELAPSE; REVIEW; SLEEP DISORDER; TENSION HEADACHE; VOMITING;

ADRENAL CORTEX HORMONES; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HEADACHE DISORDERS, SECONDARY; HEALTH SERVICES MISUSE; HUMANS; RECURRENCE; REFERRAL AND CONSULTATION; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; TRYPTAMINES;

EID: 77749264690     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2009.12.0060     Document Type: Review

References (41)

1. Steiner TJ et al., 2007. Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache. 3rd edition [online]. Available: http://216.25.88.43/upload/ NS-BASH/BASH-guidelines-2007.pdf [Accessed 17 December 2009].
2. Watson DP. Easing the pain: challenges and opportunities in headache management. Br J Gen Pract 2008; 58: 77-8.
3. Headache Classification Subcommittee of the International Headache Society (IHS). The International Classification of Headache Disorders 2nd edition 1st revision (May, 2005). Cephalalgia 2005; 25: 460-5.
4. Olesen J et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26: 742-6.
5. Headache Classification Subcommittee of the International Headache Society (IHS). The International Classification of Headache Disorders (2nd edition). Cephalalgia 2004; 24(suppl 1): 1-160.
6. Bahra A et al. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003; 43: 179-90.
7. Wilkinson SM et al. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 2001; 41: 303-9.
8. Zeeberg P et al. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006; 66: 1894-8.
9. Paemeleire K et al. Medication-overuse headache in patients with cluster headache. Neurology 2006; 67: 109-13.
10. Stovner LJ et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007; 27: 193-210.
11. Meskunas CA et al. Medications associated with probable MOH reported in a tertiary care headache center over a 15-year period. Headache 2006; 46: 766-72.
12. D'Amico D et al. Application of revised criteria for chronic migraine and MOH in a tertiary headache centre. Neurol Sci 2008; 29: S158-60.
13. Diener H-C, Katasarva Z. Analgesic/abortive overuse and misuse in chronic daily headache. Curr Pain Headache Rep 2001; 5: 545-50.
14. Scottish Intercollegiate Guidelines Network, 2008. 107: Diagnosis and management of headache in adults. A national clinical guideline [online]. Available: http://www.sign.ac.uk/pdf/sign107.pdf [Accessed 17 December 2009].
15. Joint Formulary Committee. British National Formulary. Edition 58. London: BMJ Group and RPS Publishing, September 2009.
16. Bigal ME et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008; 48: 1157-68.
17. Katsarava Z et al. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 2001; 57: 1694-8.
18. Grande RB et al. The Severity of Dependence Scale detects people with medication overuse. The Akershus study of chronic headache. J Neurol Neurosurg Psychiatr 2009; 80: 784-9.
19. Mathew NT et al. Drug induced refractory headache - clinical features and management. Headache 1990; 30: 634-8.
20. Atasoy HT et al. Psychiatric comorbidity in MOH patients with pre-existing headache type of episodic tension-type headache. Eur J Pain 2005; 9: 285-91.
21. Diener H-C, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol 2004; 3: 475-83.
22. Rapoport AM. MOH: awareness, detection and treatment. CNS Drugs 2008; 22: 995-1004.
23. Katsarava Z et al. MOH. Curr Neurol Neurosci Rep 2009; 9: 115-9.
24. Linde K et al. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev 2009, Issue 1. Art No.: CD001218. DOI: 10.1002/ 14651858.CD001218.pub2. [Last assessed as up-to-date: 14 April 2008].
25. Silverman K et al. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992; 327: 1109-14.
26. Bøe MG et al. Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy. Eur J Neurol 2009; 16: 705-12.
27. Mathew NT. Amelioration of ergotamine withdrawal symptoms with naproxen. Headache 1987; 27: 130-3.
28. Bøe MG et al. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology 2007; 69: 26-31.
29. Pageler L et al. Prednisone vs. placebo in withdrawal therapy following MOH. Cephalalgia 2008; 28: 152-6.
30. Krymchantowski AV, Moreira PF. Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia 2003; 23: 982-93.
31. Diener H-C et al. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007; 27: 814-23.
32. Mei D et al. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Clin Neuropharmacol 2006; 29: 269-75.
33. Katsarava Z et al. Rates and predictors for relapse in MOH: a 1-year prospective study. Neurology 2003; 60: 1682-3.
34. Katsarava Z et al. MOH: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 2005; 25: 12-5.
35. Suhr B et al. Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy. Cephalalgia 1999; 19: 44-9.
36. Rossi P et al. MOH: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia 2008; 28: 1196-200.
37. Descombes S et al. Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study. Headache 2001; 41: 178-82.
38. Zeeberg P et al. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006; 26: 1192-8.
39. Rossi P et al. Advice alone vs. structured detoxification programmes for MOH: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 2006; 26: 1097-105.
40. Hagen K et al. Management of MOH: 1-year randomized multicentre open-label trial. Cephalalgia 2009; 29: 221-32.
41. Clinical Knowledge Summaries. Headache - medication overuse. August 2009 [online]. Available: http://www.cks.nhs.uk/headache-medication- overuse#-393230 [Accessed 17 December 2009].